EpiVax Wins $600K SBIR Grant to Develop Vaccine Against H. Pylori | GenomeWeb

NEW YORK, May 5 (GenomeWeb News) - The US National Institutes of Health awarded EpiVax a $600,000 Phase I Small Business Innovation Research grant to develop a vaccine to Helicobacter pylorus, a common cause of peptic ulcers, the company said last week.

 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: RNA-seq, ChIP-seq to determine metformin response; array-based approach to detect protozoa in blood; and more.

Fast Company takes a look at startups in the nutrigenomic space that aim to offer personalized diet advice.

In a glamorous event, the Breakthrough Foundation gave out more than $25 million in prizes to researchers.

Immunotherapy might treat cancer, but it also appears to come with a risk of a number of side effects, the New York Times reports.